An overview of randomized phase III clinical trials of cancer nanomedicines

Thumbnail Image
1-s2.0-S2949713224000867-main.pdf (795.91 KB)
Identifiers
URI: https://hdl.handle.net/10641/7501
ISSN: 2097-2563
DOI: 10.1016/j.cpt.2024.10.001

Publication date

2025-07

Start date of the public exhibition period

End date of the public exhibition period

Authors

Advisors

Journal Title

Journal ISSN

Volume Title

Publisher

Metrics
Google Scholar
Share
Export

Research Projects

Organizational Units

Journal Issue

Doctoral program

Description

Publisher Copyright: © 2024 The Author(s)

Keywords

Antineoplastic drugs, Chemotherapy, Clinical trials, Drug delivery systems, Nanomedicine, Personalized medicine, Cancer Research, Pathology and Forensic Medicine, Histology, Oncology, SDG 3 - Good Health and Well-being, Journal Article, Review, Yes, yes

Citation

Melo, M N, Amaral, R G, Melo de Andrade, L R, Severino, P, Blanco-Llamero, C, Andrade, L N & Souto, E B 2025, 'An overview of randomized phase III clinical trials of cancer nanomedicines', Cancer Pathogenesis and Therapy, vol. 3, no. 4, pp. 322-336. https://doi.org/10.1016/j.cpt.2024.10.001

Collections

FACULTAD DE CIENCIAS DE LA SALUD